Nuclear Power Is the Energy Story of the Decade. This Stock Is Built to Last.

Cameco reported 2025 revenue of $3.48 billion (+11% YoY) and EPS surged 114.9% vs 2024, while uranium prices rose ~30% over the past year; the company produced 15% of global uranium in 2025 (164 million lbs total) and maintains strong margins (net margin 16.93%) and a low debt-to-equity ratio (0.14). Key fundamentals include world-class high-grade mines (McArthur River avg grade 6.48% producing through 2044; Cigar Lake avg grade 16.33% through 2036), a $1.9 billion, 22 million lb supply deal with India (2027–2035), and a 49% stake in Westinghouse backing AP1000 reactor demand. Geopolitical shock from the Strait of Hormuz closure and accelerated global reactor builds (projected uranium demand 107,000–150,000 tons by 2040 vs ~82,000 tons current production) create sector tailwinds that make Cameco a likely beneficiary; shares are up ~17.5% YTD and ~161% over 12 months.

Analysis

Cameco’s structural advantage is not just geology or balance sheet; it is timing and counterparty optionality. Western buyers will increasingly value long-term, contractually predictable non-Russian/Kazakh supply, which creates a persistent premium for large, diversified suppliers and lengthens contract tenors — a pricing mechanism that can compound realized margins even if spot prices mean-revert.

The likely multi-year demand shock is lumpy: reactor builds and restarts create step-function increases in contracted offtake rather than a smooth ramp, so expect episodic procurement windows where incumbents capture oversized share and smaller miners struggle to finance new capacity. That amplifies idiosyncratic issuer risk among juniors and concentrates geopolitical exposure into a handful of major suppliers and conversion/enrichment providers.

Key tail risks live on the supply side and policy track. Fast inventory releases, downblending programs, or a pause in new-build schedules (permitting, financing or public pushback) could shave the marginal tonne demand profile within quarters; conversely, accelerated national stockpiling or sanctions-driven reshuffles could institutionalize a premium for certified Western origins over many years.

For portfolio construction, prioritize capacity, contract vintage, and downstream integration when sizing exposure. Stepped option structures and pair trades can monetize the dispersion between large-cap integrated producers and high-beta juniors while keeping directional uranium exposure limited to a controlled share of commodity allocation over a 6–36 month horizon.

Key Decisions for Investors

• Long CCJ equity sized as 1–2% of fund NAV with a 12–24 month horizon; implement a 25% trailing stop and trim into rallies. Rationale: buy quality, de-risked exposure to capture contract-cycle re-pricing; target asymmetric return (50–100%) if contract rollovers and tender wins continue.
• Replace broad-uranium spot exposure with a pair: long CCJ (50% weight) / short URNM (50% weight) for 6–12 months to capture carry and quality-premium. Risk/reward: limited downside vs pure spot ETF; expect outperformance if large caps re-rate and juniors lag—sell to neutral on underperformance >20%.
• Buy a 9–15 month call spread on CCJ (debit structure) to cap premium while keeping upside exposure; size so max premium is <0.5% NAV. Rationale: levered participation in contract-fueled rallies with defined loss if macro noise (e.g., Strait developments) triggers short-term pullbacks.
• Selective long on nuclear services/engineering (e.g., BWXT) for 12–36 months to play downstream capex (supply chain beneficiaries). Position size 0.5–1% NAV; diversification benefit reduces pure-commodity beta and captures multi-year build cadence.
• Maintain a hedge: buy protection (long puts) on the uranium ETF URA or a small-cap uranium basket for 3–6 months sized to offset 50% of directional spot exposure. Use this to guard against rapid inventory releases or a political recalibration that depresses spot prices.